Back to Journals » Clinical and Experimental Gastroenterology » Volume 11

A study of the circulating fibroblast growth factor 21 as a novel noninvasive biomarker of hepatic injury in genotype-4 chronic hepatitis C: Egyptian patients and their response to direct-acting antiviral agents

Total article views   Abstract views HTML views PDF downloads Totals
2,241 Dovepress* 1,982 177+ 308 2,159
PubMed Central* 0 82 31 82
Totals 1,982 259 339 2,241
*Since 24 October 2018
+Since July 2016

View citations on PubMed Central and Google Scholar